Page last updated: 2024-11-02

orphenadrine and Tinnitus

orphenadrine has been researched along with Tinnitus in 2 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Tinnitus produced by middle-ear myoclonus is a rare condition."1.32Objective high-frequency tinnitus of middle-ear myoclonus. ( Abdul-Baqi, KJ, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coelho, C1
Figueiredo, R1
Frank, E1
Burger, J1
Schecklmann, M1
Landgrebe, M1
Langguth, B1
Elgoyhen, AB1
Abdul-Baqi, KJ1

Trials

1 trial available for orphenadrine and Tinnitus

ArticleYear
Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.
    Audiology & neuro-otology, 2012, Volume: 17, Issue:3

    Topics: Adult; Aged; Amitriptyline; Clonidine; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central;

2012

Other Studies

1 other study available for orphenadrine and Tinnitus

ArticleYear
Objective high-frequency tinnitus of middle-ear myoclonus.
    The Journal of laryngology and otology, 2004, Volume: 118, Issue:3

    Topics: Audiometry, Pure-Tone; Ear Diseases; Ear, Middle; Hearing Loss, Bilateral; Hearing Loss, Sensorineur

2004